Combination treatment with hypofractionated radiotherapy plus IL-2/anti-IL-2 complexes and its theranostic evaluation

BACKGROUND: Immunogenic radiotherapy (RT) can act synergistically with immune checkpoint blockers (ICBs). However, alternatives are needed for non-responding patients and those with pre-existing or ICB-induced autoimmune symptoms. Combination of RT with IL-2 could be an alternative. But IL-2 has a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Hua, Hettich, Michael, Gaedicke, Simone, Firat, Elke, Bartholomä, Mark, Niedermann, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390578/
https://www.ncbi.nlm.nih.gov/pubmed/30808414
http://dx.doi.org/10.1186/s40425-019-0537-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390578/
https://www.ncbi.nlm.nih.gov/pubmed/30808414
http://dx.doi.org/10.1186/s40425-019-0537-9

Ejemplares similares